Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,606,398
-$287,447 QoQ
Shares Held
144,961
+17.3% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. URGN ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in URGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,606,398 | 144,961 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,893,845 | 123,563 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,458,663 | 73,116 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $32,742 | 2,390 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,073 | 2,900 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $212,690 | 19,971 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $293,242 | 23,090 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $57,386 | 3,420 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $48,465 | 3,231 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $73,200 | 4,880 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $68,915 | 4,919 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,206 | 503 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,194 | 454 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $4,026 | 454 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,777 | 454 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,422 | 540 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,578 | 296 | Shares | Defined | 2022-05-13 | |
| 2021-06-30 | $726,897 | 47,603 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $927,306 | 47,603 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $857,806 | 47,603 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,151,670 | 59,703 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,942,378 | 227,503 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $5,612,517 | 314,603 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||